ECRI

[PODCAST] Hear what ECRI's president and CEO, Dr. Marcus Schabacker, says about the risks for fast-tracked #COVID-19 #vaccines in this week's edition of Smart Healthcare Safety https://hubs.la/H0z9gBc0 #coronavirus #COVIDvaccines #vaccines #vaccinetrials #virus #pandemic

Looking for strategies for surgical patient safety? Check out this new Deep Dive on the top surgical-related adverse events reported to ECRI and the Institute for Safe Medication Practices (ISMP) Patient Safety Organization (PSO). Get a systems approach to improving outcomes and reducing risk. Download exec brief now: https://hubs.la/H0z78cz0

[BLOG] ECRI's Dr. Brigitta Mueller says creating a culture of patient safety is crucial to protecting patients and staff. Read: Keep Healthcare Workers Safe to Improve Patient Safety https://hubs.la/H0yDDfx0

Wishing you all a Happy and Safe Halloween! Enjoy some spooky pics from today's virtual Halloween party. We had so much fun! Whatever you do to celebrate, remember to wear a #mask, stay 6 feet apart, and #washyourhands frequently! #happyhalloween #spookyseason #TrickOrTreat

Post-Intensive Care Syndrome (#PICS) has the potential to negatively affect tens of thousands of discharged #COVID-19 survivors. 1/3 of PICS patients never return to work. Learn how to recognize the symptoms and the hidden dangers. ECRI's new eBook can help. Download now for free: https://hubs.la/H0yRWy40 #COVID #Coronavirus #ICU #Post-ICU #patients #clinicians #healthcare

[NEWS] ECRI and HealthEquip have teamed up to provide #N95-style mask testing needed during the #COVID-19 pandemic. ECRI’s N95-Style Mask Testing Program provides assurance on whether masks that an healthcare organization plans to purchase meets industry standards. In a recent study, ECRI found that up to 70 percent of the Chinese #KN95 masks it tested do not meet U.S. standards for effectiveness. https://hubs.la/H0yVf140

Join us Nov 4 and 5 for "Elevating the Value Analysis Process." This 2-day virtual meeting will provide insights on improving physician engagement and the importance of evidence-based guidance during the value analysis process. The program is free and open to hospital and health system supply chain and value analysis teams. https://hubs.la/H0ySfRb0 #valueanalysis #supplychain #hospitals #healthcare #healthsystem #evidencebasedmedicine #EBM

Drugs modeled on natural immune responses are joining the fight against #COVID-19. Learn about Colchicine and monoclonal antibodies that target the coronavirus spike (S) protein in this edition of the Patient-Centered Outcomes Research Institute - PCORI COVID-19 Scan from ECRI's Horizon Scanning team. https://hubs.la/H0yC6k40

Are you one of the <1,000 people affected by #epithelioidsarcoma per year in the US? Help us understand the impact of new drug in the fight against epithelioid sarcoma. Contact us today: https://hubs.la/H0xLhTd0 #sarcoma #cancer

[Oct 27] Timothy Browne, ECRI's Executive Director of Supply Chain Services, is presenting at the Association of Healthcare Value Analysis Professionals - AHVAP 2020 Virtual Conference about how to vet non-traditional suppliers during the #COVID-19 pandemic. Tim will define the process, describe methods for properly testing #PPE, and guide value analysis teams in navigating the non-traditional supplier field with confidence. https://hubs.ly/H0yBDTb0

Why does participation in a federally listed Patient Safety Organization (PSO) matter? Join us Tuesday, Oct. 27, for a special presentation by ECRI's Brigitta Mueller, executive director of patient safety, risk, and quality. Brigitta will de-mystify legal challenges to the Patient Safety and Quality Improvement Act and pull back the curtain on how a PSO membership improves patient safety and quality care. You won't want to miss this American Hospital Association webinar! Register now: https://hubs.la/H0ywtcX0 Institute for Safe Medication Practices

[TODAY] ECRI President and CEO Marcus Schabacker is speaking at 2:30 today at FDA's Vaccines Committee meeting, saying that under no circumstances should #COVID-19 #vaccines be authorized with fewer than 6 months follow-up data from full trial cohort. Access live streaming presentation here: https://hubs.la/H0ypC8t0